|
| Press Releases |
|
 |
|
| Wednesday, September 1, 2021 |
|
|
聯想控股2021上半年收入2285.7億元 歸母淨利46.9億元 |
| 聯想控股股份有限公司（「聯想控股」或「公司」；股份代號：3396.HK）於2021年8月31日公佈截至2021年6月30日止（「報告期」）未經審核的中期業績。 more info >> |
|
|
Legend Holdings Revenue and Net Profit Attributable to Equity Holders of the Company Stood at RMB 228.57 Billion and RMB 4.69 Billion in 1H2021 |
| Legend Holdings Corporation ("Legend Holdings" or the "Company"; stock code: 3396.HK) announced the unaudited interim results of the six months ended June 30, 2021 (the "Reporting Period") on August 31, 2021. more info >> |
|
|
联想控股（3396.HK）中期归母净利大增6.36倍至人民币46.91亿元 |
| 据信报财经新闻报道，7月内地公布上半年各项经济数据，国内生产总值保持了两位数的增长，说明在全球疫情走势仍错综复杂的情形下，中国经济保持了实足的韧性与成长性。 more info >> |
|
|
聯想控股（3396.HK）中期歸母淨利大增6.36倍至人民幣46.91億元 |
| 據信報財經新聞報道，7月內地公佈上半年各項經濟數據，國內生產總值保持了兩位數的增長，說明在全球疫情走勢仍錯綜複雜的情形下，中國經濟保持了實足的韌性與成長性。 more info >> |
|
| Friday, July 30, 2021 |
|
|
君联资本投资生物计算平台百图生科A轮融资 |
| 生物计算平台企业百图生科近日完成上亿美元A轮融资，君联资本参与了此次投资，本轮融资将主要用于技术研发和人才引进。 more info >> |
|
|
君聯資本投資生物計算平台百圖生科A輪融資 |
| 生物計算平台企業百圖生科近日完成上億美元A輪融資，君聯資本參與了此次投資，本輪融資將主要用於技術研發和人才引進。 more info >> |
|
|
Legend Capital invests in Series A funding round of BioMap, a biological computing platform |
| BioMap, a biological computing platform enterprise, has recently completed the Series A funding round worth over a hundred million US dollars, which Legend Capital participated in. The funds will be used to for R&D and talent recruitment. more info >> |
|
| Monday, July 19, 2021 |
|
|
Dook Media, a Full Copyright Operator, invested by Legend Capital Successfully Listed on the China GEM |
| On July 19th, Dook Media Group Limited (stock code: 301025), invested by Legend Capital, was successfully listed on the Growth Enterprise Market in China. With public offering of 40.01 million shares, the stock closed at RMB31.66 per share, up 1942% from its initial price. Its total market value reached over RMB12.6 billion. more info >> |
|
| Thursday, July 15, 2021 |
|
|
Legend Capital continues to be optimistic about technological innovation, with great opportunities in tech investment |
| On July 8-9, 2021, Richard Li, the President of Legend Capital, attended the 10th Private Equity Investment Summit Forum held by Noah Holdings and delivered a speech on the topic of technological innovation, sharing his views on information technology, biotechnology and new energy, as well as the long-term prospects. more info >> |
|
| Friday, July 9, 2021 |
|
|
康诺亚成功IPO，联想之星早期创新药投资实力再获验证 |
据联想控股微空间报导，7月8日，生物科技公司康诺亚生物医药科技有限公司（下称「康诺亚生物」）正式挂牌港交所，发行价为53.30港元。上市当天，康诺亚开盘大涨46.34%，市值达211亿港元。
more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
維昇藥業（2561.HK）維臻高(R)獲批：重長效生長激素王者登場 重構百億市場的商業天花板
Feb 25, 2026 14:58 HKT/SGT
|
|
|
Hong Kong Tech Delegation Heading for Market Expansion at Mobile World Congress 2026
Feb 25, 2026 14:54 HKT/SGT
|
|
|
CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
Feb 25, 2026 12:46 HKT/SGT
|
|
|
Shoucheng Holdings (00697.HK) Sees Long-Term International Capital Rotation as Robotics Portfolio Enters Harvest Phase
Feb 25, 2026 12:23 HKT/SGT
|
|
|
首程控股（00697.HK）迎來國際長線接盤 機器人產業生態進入價值收割期
Feb 25, 2026 12:23 HKT/SGT
|
|
|
首程控股（00697.HK）迎来国际长线接盘 机器人产业生态进入价值收割期
Feb 25, 2026 12:23 HKT/SGT
|
|
|
ベイシアのスーパーマーケット内の冷蔵・冷凍庫の温度点検・記録業務を富士通のIoT可視化ソリューションにより自動化
Feb 25, 2026 12:00: JST
|
|
|
Beisia Automates Supermarket Refrigerator Temperature Monitoring and Recording with Fujitsu's IoT Visualization Solution
Feb 25, 2026 12:00 JST
|
|
|
國泰君安國際獲批使用SIMM 衍生品風險管理接軌國際標準
Feb 25, 2026 10:34 HKT/SGT
|
|
|
国泰君安国际获批使用SIMM 衍生品风险管理接轨国际标准
Feb 25, 2026 10:34 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 22:30: JST
|
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 21:30 HKT/SGT
|
|
|
TANAKA to Provide Medals for the Tokyo Marathon 2026 That Represent All the Participants in the Event with Woven Lines
Feb 24, 2026 22:00 JST
|
|
|
康哲藥業（867.HK/8A8.SG）：創新藥磷酸蘆可替尼乳膏增加特應性皮炎（AD）適應症中國上市許可申請獲受理並獲納入優先審評
Feb 24, 2026 20:31 HKT/SGT
|
|
|
康哲药业（867.HK/8A8.SG）：创新药磷酸芦可替尼乳膏增加特应性皮炎（AD）适应症中国上市许可申请获受理并获纳入优先审评
Feb 24, 2026 20:19 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
